About Institut claudius regaud
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Institut claudius regaud
During the past decade, Institut claudius regaud conducted 417 clinical trials. In the 10-year time frame, 417 clinical trials started and 63 clinical trials were completed, i.e. on
average, 15.1% percent of trials that started reached the finish line to date. In the past 5 years, 230 clinical trials started and 50 clinical trials were completed. i.e. 21.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Institut claudius regaud" #1 sponsor was "Institut Claudius Regaud" with 82 trials, followed by "UNICANCER" with 68 trials
sponsored, "Centre Leon Berard" with 28 trials sponsored, "Celgene" with 22 trials sponsored and "Janssen Research & Development, LLC"
with 22 trials sponsored. Other sponsors include 353 different institutions and
companies that sponsored additional 131 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Institut claudius regaud"
#1 collaborator was "National Cancer Institute, France" with 15 trials as a collaborator, "Pfizer" with 12 trials as a collaborator, "AstraZeneca" with 11 trials as a collaborator, "Merck Sharp & Dohme LLC" with 11 trials as a collaborator and "Roche Pharma AG" with 10 trials as a collaborator. Other collaborators include 339 different institutions and companies that were
collaborators in the rest 236 trials.
Clinical Trials Conditions at Institut claudius regaud
According to Clinical.Site data, the most researched conditions in "Institut claudius regaud" are
"Breast Cancer" (46 trials), "Ovarian Cancer" (19 trials), "Multiple Myeloma" (17 trials), "Prostate Cancer" (16 trials) and "Melanoma" (13 trials). Many other conditions were trialed in "Institut claudius regaud" in a lesser frequency.
Clinical Trials Intervention Types at Institut claudius regaud
Most popular intervention types in "Institut claudius regaud" are "Drug" (405 trials), "Other" (89 trials), "Procedure" (49 trials), "Radiation" (43 trials) and "Biological" (38 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (26 trials), "Atezolizumab" (15 trials), "Azacitidine" (15 trials), "Dexamethasone" (15 trials) and "Gemcitabine" (15 trials). Other intervention names were less common.
Clinical Trials Genders at Institut claudius regaud
The vast majority of trials in "Institut claudius regaud" are
449 trials for "All" genders, 100 trials for "Female" genders and 30 trials for "Male" genders.
Clinical Trials Status at Institut claudius regaud
Currently, there are NaN active trials in "Institut claudius regaud".
undefined are not yet recruiting,
189 are recruiting,
96 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 208 completed trials in Institut claudius regaud,
6 suspended trials,
and 43 terminated clinical trials to date.
Out of the total trials that were conducted in Institut claudius regaud, 113 "Phase 1"
clinical trials were conducted, 217 "Phase 2" clinical
trials and 156 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 14 trials, and there were
also 83 trials that are defined as “Not Applicable".
Departments of Institut claudius regaud
Institut claudius regaud has several departments that took part in Clinical trials: "IUCT Oncopole; Hematologie" - 16 trials, "Institut Claudius Regaud; Departement Oncologie Medicale" - 28 trials